| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 02/14/2002 | WO2002012263A1 Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses |
| 02/14/2002 | WO2002012261A1 Avermectin derivatives |
| 02/14/2002 | WO2002011668A2 5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients |
| 02/14/2002 | WO2001075139A8 Reversible chemical modification of nucleic acids and improved method for nucleic acid hybridization |
| 02/14/2002 | WO2001068663B1 Nucleoside compounds and uses thereof |
| 02/14/2002 | WO2001029055A3 Novel oligosaccharides, preparation method and pharmaceutical compositions containing same |
| 02/14/2002 | WO2000067698A3 Method for controlling the fidelity and execution of reverse transcriptase by incorporating and polymerising nucleotide analogues acceptable as substrates without blocking its elongation |
| 02/14/2002 | US20020019363 Viricides for hepatitis c |
| 02/14/2002 | CA2569615A1 Nucleic acid binding compounds containing pyrazolo[3,4-d] pyrimidine analogues of purin-2,6-diamine and their uses |
| 02/13/2002 | EP1178999A2 L-ribo-lna analogues |
| 02/12/2002 | US6346627 Intermediates in the synthesis of 1,3-oxathiolane nucleoside enantiomers |
| 02/12/2002 | US6346615 Spiroadamantyl dioxetanes bearing an alkoxy substituent, and an aromatic substituent on the dioxetane ring can be activated to chemiluminesce if the aromatic substituent bears a moiety that is cleaved by an enzyme |
| 02/12/2002 | US6346611 High affinity TGfβ nucleic acid ligands and inhibitors |
| 02/12/2002 | US6346413 Polymer arrays |
| 02/07/2002 | WO2002010432A2 Triphosphate oligonucleotide modification reagents and uses thereof |
| 02/07/2002 | WO2002009701A1 Use of selective adenosine a1 receptor agonists, antagonists and allosteric enhancers to manipulate angiogenesis |
| 02/07/2002 | US20020016976 Mutant multi-substrate enzyme which accepts at least one orthogonal substrate analog, whereby catalytic activity results in combination of all or part of orthogonal substrate with other substrate of enzyme; drug screening |
| 02/07/2002 | US20020016472 Protecting groups with increased photosensitivities |
| 02/07/2002 | US20020015961 Hydrocarbyldithiomethyl-modified compound; for use in chemically synthesizing oligonucleotides and for sequencing |
| 02/07/2002 | US20020015954 Sets of oligonucleotide-binding e-tag probes |
| 02/07/2002 | CA2414623A1 Use of selective adenosine a1 receptor agonists, antagonists and allosteric enhancers to manipulate angiogenesis |
| 02/06/2002 | EP1178051A2 Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside |
| 02/06/2002 | EP1177202A1 4'-c-ethynyl purine nucleosides |
| 02/06/2002 | EP1177201A1 4'-c-ethynyl pyrimidine nucleosides |
| 02/06/2002 | EP0882059B1 Solid phase synthesis of oligonucleotide n3-'p5'- phosphoramidates |
| 02/06/2002 | CN1334814A Antiviral nucleoside analogues |
| 02/05/2002 | US6344460 Propynyl uracils |
| 02/05/2002 | US6344447 Administering mixture of nucleosides; anticancer agent |
| 02/05/2002 | US6344320 Electrophoresis of nascent proteins |
| 02/05/2002 | US6344318 A selex method determining three dimensional structure of nucleic acid ligands by identifying a ligand to a specific target and modifying the nucleotides with a monomer to allow the ligand to mimic the structure and bind the target |
| 02/05/2002 | US6344316 Nucleic acid analysis techniques |
| 01/31/2002 | WO2002008446A2 Synthesis and antiviral evaluation of nucleic acid based (nab) libraries |
| 01/31/2002 | WO2002008241A2 Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 01/31/2002 | US20020013306 Terpyridine-platinum(ii) complexes |
| 01/31/2002 | US20020013289 P2Y2 and/or P2Y4 purinergic receptor agonists e.g., nucleotides of adenosine, cytidine and uridine, dinucleotides and analogs; treating vaginal dryness associated with menopause, chemotherapy, and diseases; vulvar pain |
| 01/31/2002 | US20020013287 Nucleosides, nucleoside analogs, abasic nucleosides, or heterocyclic derivatives linked by a phophodiester, a phosphorothioate or phosphonate group; sustained release; anticarcinogenic agents, viricides and microbiocides |
| 01/31/2002 | CA2725819A1 Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 01/31/2002 | CA2415368A1 Synthesis and antiviral evaluation of nucleic acid based (nab) libraries |
| 01/30/2002 | EP1176150A1 Process for the preparation of trifluorothymidine derivatives |
| 01/30/2002 | EP1175432A1 Processes for the synthesis of oligomers using phusphoramidite compositions |
| 01/30/2002 | EP1102782A4 Structural analogs of amine bases and nucleosides |
| 01/30/2002 | EP1045897B1 Enzyme catalyzed therapeutic agents |
| 01/30/2002 | CN1333784A Benzylmaltosides as inhibitors of smooth muscle cell proliferation |
| 01/29/2002 | US6342484 Method and compositions for promotion of wound treatment |
| 01/29/2002 | US6342244 Hydrophilic polymer covalently yet reversibly linked to a amine-containing ligand through a dithiobenzyl linkage; modification of various substrates, such as polypeptides, drugs and liposomes; upon cleavage of the linkage, the ligand |
| 01/29/2002 | CA2048347C Process for the preparation of deoxynucleosides |
| 01/24/2002 | US20020010147 High purity of the diastereoisomer; acidifying pH, making an aqueous lysate from the yeast, microfiltration of lysate, absorption on a weak acid resin, elution with inorganic acid, decoloration, reverse osmosis, adding acid to form salt |
| 01/24/2002 | US20020009748 Nucleobase heterocyclic combinatorialization |
| 01/24/2002 | US20020009737 Kits employing oligonucleotide-binding e-tag probes |
| 01/23/2002 | EP1174141A2 Modulation of TH1/TH2 cytokine expression by ribavirin and ribavirin analogs in activated t-lymphocytes |
| 01/23/2002 | EP1173456A1 Secreted proteins and nucleic acids encoding them |
| 01/23/2002 | EP1173222A2 Conjugate having a cleavable linkage for use in a liposome |
| 01/23/2002 | EP1049744B1 Asymmetric cyanine dye quenchers |
| 01/23/2002 | EP0813539A4 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom |
| 01/23/2002 | EP0763047B1 Novel method of producing nucleosides |
| 01/23/2002 | CN1332747A 2'-fluoronucleosides |
| 01/22/2002 | US6340754 Phosphorus containing cyclic nucleotides |
| 01/22/2002 | US6340749 Preparation of nucleoside phosphoramidites and oligonucleotide synthesis |
| 01/22/2002 | US6340747 Complexed to rare earth metal cryptate label; detection and isolation of nucleic acids |
| 01/17/2002 | WO2002004475A1 9-substituted adenine derivatives as prodrug regulators of cell and tissue function |
| 01/17/2002 | WO2002004474A1 Adenosine compound and pharmaceutical composition containing the same |
| 01/17/2002 | WO2002003997A1 Pyrido[2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides |
| 01/17/2002 | WO2001068064A3 Use of cdp-choline for the prophylactic treatment of cerebral ischemia |
| 01/17/2002 | WO2001031051A3 Antisense modulation of protein kinase c-theta expression |
| 01/17/2002 | WO2001007087A3 Enzyme catalyzed anti-infective therapeutic agents |
| 01/17/2002 | CA2416199A1 Adenosine compound and pharmaceutical composition containing the same |
| 01/17/2002 | CA2405798A1 Pyrido¬2,3-d|pyrimidine and pyrimido¬4,5-d|pyrimidine nucleosides |
| 01/16/2002 | EP1172369A1 Synthesis of 2-deoxy-2-fluoro-arabinose derivates |
| 01/16/2002 | EP1171635A1 Electronically mediated nucleic acid amplification in nasba |
| 01/16/2002 | EP1082012A4 Novel nucleosides having bicyclic sugar moiety |
| 01/16/2002 | EP0854877B1 Metallocene-phosphoramidite conjugates, process for their preparation and their use |
| 01/16/2002 | EP0782580A4 Parallel selex |
| 01/15/2002 | US6339151 Forming compounds using a nucleic acid base with a phosphorous halide to form drugs for nonproliferation of cells |
| 01/15/2002 | US6339073 Uses of nicotinamide adenine dinucleotide and its derivatives for treatment of malignant and infectious diseases |
| 01/15/2002 | US6339066 Antisense oligonucleotides which have phosphorothioate linkages of high chiral purity and which modulate βI, βII, γ, δ, Ε, ζ and η isoforms of human protein kinase C |
| 01/15/2002 | US6339060 For therapy of infections caused by microorganisms |
| 01/15/2002 | US6338963 Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
| 01/10/2002 | WO2002002584A1 Base analogues |
| 01/10/2002 | US20020004594 Phosphoramidates and methods therefor |
| 01/10/2002 | US20020004593 Methods of making modified nucleosides |
| 01/10/2002 | US20020004230 Broth for biosynthesis of deoxyribonucleic acids |
| 01/10/2002 | US20020004046 Includes use of neutralizing antibody, high affinity antibodies, and viricide (ribavirin, amantadine, rimantadine, or a neuraminidase inhibitor); useful for controlling/treating respiratory syncytial virus in young children |
| 01/10/2002 | CA2412292A1 Base analogues |
| 01/09/2002 | EP1169329A1 Oligonucleotides having alkylphosphonate linkages and methods for their preparation |
| 01/09/2002 | EP1169309A1 Propynyl uracils |
| 01/09/2002 | EP1169046A1 Pulmonary delivery of protonated/acidified nucleic acids |
| 01/09/2002 | EP1017841A4 Chromatographic method for mutation detection using mutation site specifically acting enzymes |
| 01/09/2002 | CN1330658A Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
| 01/08/2002 | US6337333 Method of treating autoimmune disease with fludarabine-5′-monophosphate |
| 01/08/2002 | US6337209 Molecular constructs containing a carcinoembryonic antigen regulatory sequence |
| 01/08/2002 | US6337197 Coenzymes useful for the synthesis of L-carnitine |
| 01/03/2002 | WO2002000676A1 Purine derivatives |
| 01/03/2002 | WO2002000200A1 Novel process for preparing crystalline particles |
| 01/03/2002 | WO2001042265A3 N6 heterocyclic 8-modified adenosine derivatives |
| 01/03/2002 | WO2001034618A3 Synthesis of 2'-deoxy-l-nucleosides |
| 01/03/2002 | US20020001808 Methods employing oligonucleotide-binding e-tag probes |
| 01/02/2002 | EP1167972A2 Enzyme catalyzed therapeutic agents |
| 01/02/2002 | EP1165693A2 Squaraine dyes |
| 01/02/2002 | EP1165584A1 2'-substituted rna preparation |
| 01/02/2002 | EP1165564A2 Process for preparing inhibitors of nucleoside metabolism |